R
301333
vs
TMO
R
301333
TMO
Over the past 12 months, R&G PharmaStudies Co Ltd has significantly outperformed TMO, delivering a return of +54% compared to the TMO's +21% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
301333
TMO
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
R&G PharmaStudies Co Ltd Intrinsic Value
LOCKED
TMO Intrinsic Value
LOCKED
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
R
|
R&G PharmaStudies Co Ltd
SZSE:301333
|
68.62
CNY
|
|||||
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
524.57
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
301333, TMO
301333, TMO
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
R
|
R&G PharmaStudies Co Ltd
Revenue
|
|||||||||||
|
|
Thermo Fisher Scientific Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
301333, TMO
301333, TMO
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
R
|
R&G PharmaStudies Co Ltd
SZSE:301333
|
|||||||||
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
R&G PharmaStudies Co Ltd
34.7%
TMO
40.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
R
|
R&G PharmaStudies Co Ltd | ||||
|
|
Thermo Fisher Scientific Inc | ||||
Operating Margin
R&G PharmaStudies Co Ltd
15.2%
TMO
18.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
R
|
R&G PharmaStudies Co Ltd | ||||
|
|
Thermo Fisher Scientific Inc | ||||
Net Margin
R&G PharmaStudies Co Ltd
16.1%
TMO
15%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
R
|
R&G PharmaStudies Co Ltd | ||||
|
|
Thermo Fisher Scientific Inc | ||||
FCF Margin
R&G PharmaStudies Co Ltd
11.2%
TMO
14.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
R
|
R&G PharmaStudies Co Ltd | ||||
|
|
Thermo Fisher Scientific Inc | ||||
ROE
R&G PharmaStudies Co Ltd
7.2%
TMO
13%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
R
|
R&G PharmaStudies Co Ltd | ||||
|
|
Thermo Fisher Scientific Inc | ||||
ROA
R&G PharmaStudies Co Ltd
5.8%
TMO
6.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
R
|
R&G PharmaStudies Co Ltd | ||||
|
|
Thermo Fisher Scientific Inc | ||||
ROIC
R&G PharmaStudies Co Ltd
20.2%
TMO
8.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
R
|
R&G PharmaStudies Co Ltd | ||||
|
|
Thermo Fisher Scientific Inc | ||||
ROCE
R&G PharmaStudies Co Ltd
6.6%
TMO
9.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
R
|
R&G PharmaStudies Co Ltd | ||||
|
|
Thermo Fisher Scientific Inc | ||||
Solvency Comparison
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
301333, TMO
301333, TMO
Performance Gap
301333, TMO
301333, TMO
Performance Gap Between 301333 and TMO
LOCKED
Performance By Year
301333, TMO
301333, TMO
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 301333 to other stocks
0KHE
PerkinElmer Inc
P
More expensive
vs R&G PharmaStudies Co Ltd
DHR
Danaher Corp
Cheaper
vs R&G PharmaStudies Co Ltd
207940
Samsung Biologics Co Ltd
More expensive
vs R&G PharmaStudies Co Ltd
LONN
Lonza Group AG
Cheaper
vs R&G PharmaStudies Co Ltd
Select Stock to Compare
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
|
| US |
|
Waters Corp
NYSE:WAT
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
